Accuracy of TcB Measurements During and After Phototherapy
NCT ID: NCT07080398
Last Updated: 2025-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2024-11-01
2025-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Continuous Versus Intermittent Phototherapy in Treatment of Neonatal Jaundice
NCT06386731
Transcutaneous Bilirubin Measurements in Neonates Post Phototherapy
NCT04719104
White Reflective Drape in Phototherapy for Neonatal Hyperbilirubinemia
NCT07156721
Effectiveness of Aluminum Foil vs White Linen Reflectors in Phototherapy for Neonatal Hyperbilirubinemia
NCT07266246
Broad Band Emission LED Phototherapy Source Versus Narrow Band
NCT05257369
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The researchers used Bland-Altman plots to analyze the agreement between the transcutaneous bilirubin measurements and total serum bilirubin levels.
By comparing the transcutaneous bilirubin measurements to total serum bilirubin levels using Bland-Altman plots, the researchers were able to determine the accuracy of the transcutaneous measurements in this specific population of infants undergoing phototherapy. This information is important for healthcare providers to ensure that they are using the most accurate and reliable method for monitoring bilirubin levels in infants receiving treatment for jaundice.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
term newborns
term newborns with hyperbilirubinemia requiring phototherapy
serum bilirubin level measurement
Total serum bilirubin levels and concurrent transcutaneous bilirubin measurements will be done and the results will be evaluated comperatively.
late-preterm newborns
late-preterm newborns with hyperbilirubinemia requiring phototherapy
serum bilirubin level measurement
Total serum bilirubin levels and concurrent transcutaneous bilirubin measurements will be done and the results will be evaluated comperatively.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
serum bilirubin level measurement
Total serum bilirubin levels and concurrent transcutaneous bilirubin measurements will be done and the results will be evaluated comperatively.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hyperbilirubinemia requiring phototherapy
* Indirect hyperbilirubinemia
* Newborn infants who are born between 35-42 weeks of gestation
Exclusion Criteria
* Disease states other than hyperbilirubinemia
* Congenital abnormalities
* Chromosomal abnormalities
* Poor peripheral perfusion
* Edema
1 Hour
2 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kanuni Sultan Suleyman Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seda Yilmaz Semerci
Assoc. Prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Health Sciences Istanbul KSS Training and Research Hospital
Istanbul, Kucukcekmece, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021/249
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.